User:Alexandra Helleux/Sandbox1138

From Proteopedia

Structure of MICU1

Caption for this structure

Drag the structure with the mouse to rotate

MICU 1 (Mitochondrial Calcium Uptake 1) is a key regulator of mitochondrial calcium uniporter (MCU) required to increase calcium uptake by MCU when cytoplasmic calcium concentration is high.Calcium is involved in signalling pathways in cells and because of that it plays a lot of important roles throughout the body (muscle contraction, cell growth, cell movement...)

It also regulates glucose-dependent insulin secretion in pancreatic beta-cells by regulating mitochondrial calcium uptake.


Ligands:	Ca 2+
Related:	MICU 2,MCU, EMRE
Gene:	CBARA, chromosome 10 (Homo sapiens)
Activity:	Regulator of Ca 2+ uptake in the mitochondria

1 History
2 Function
3 Structural highlights
4 Disease
5 See also
6 References

History

MICU1 was identified as an essential element of mitochondrial calcium uptake in 2010. It was crystalised in the presence of calcium chloride and methyl-pentanediol (MPD). The recent discovery of this protein doesn’t permit to have more information about its evolutionary conservation.

Function

Uniprot MICU1

MICU 1 is a regulator of Ca 2+ uptakes in mitochondria. To do this regulation, it can sense the concentration of calcium in the cytosol of the cell thanks to 2 EF-hand domains. It mainly acts on MCU which is a transmembrane uniporter channel located on the inner membrane of the mitochondria. To interact with MCU, MICU1 has to be linked to MICU2 (a paralogue protein). The entire complex of Ca2+ regulation is MICU1/MICU2/MCU/EMRE. EMRE is a protein which is required for the interaction of MCU with MICU1/MICU2.

When it is not linked to Ca2+ it has an hexameric conformation. In this conformation MICU 1 silences the activity of MCU/EMRE and stop the Ca 2+ from entering the mitochondria by blocking the entrance of the channel. When there is a lot of calcium in the intermembrane and so in the cytoplasm, Ca2+ binds to MICU1, then it changes its conformation and separates into multiple homooligomers. This leads to the opening of the “gate” in front of the MCU channel, letting the calcium enter into the matrix.

Structural highlights

MICU 1 is a ~54kDa transmembrane protein composed by an amino-terminal mitochondrial targeting sequence, a transmembrane helix and a cytosolic C-terminus which contain different important domains described after.

In absence of Ca2+, MICU1 is an homohexamer with a composed by several alpha helix (in pink), beta sheets (in orange), turns (in purple) and loops (in white). When it , it becomes a .

MICU 1 is composed by differents domains :

- (or Coiled-coil domain) : this domain permits different interactions with other proteins (MCU/MICU2) and is required to assemble free Ca2+ with homohexamer.

- : it’s a domain which permits protein-protein interactions

- There are 2 of them. They are the most important domains in MICU1 protein because they contain the Ca2+ binding region and detect the concentration of calcium in the cell. This function is necessary for the activation of signalling. An EF-hand domain is a calcium sensor. It is a helix loop helix structural domain that means that there are 2 alpha helices linked by a short loop region. Ca2+ ions are coordinated in this space thanks to ligands within the loop : in EF-1, residues concerned are Asp231, Asn233, Asp235, Glu237 and Glu242 and in EF-2 they are Asp421, Asp423, Asn425, Glu427 and Glu432. When Ca2+ binds itself to this domain, the protein changes its conformation to expose a domain that can interact with other proteins.

Disease

If MICU1 gene is modified, Ca2+ can be load in higher concentration in the mitochondry resulting Myopathy with extrapyramidal signs (MPXPS). This is an autosomal recessive disorder characterized by early-onset proximal muscle weakness with a static course and moderately to grossly elevated serum creatine kinase levels accompanied by learning difficulties. Most patients develop subtle extrapyramidal motor signs that progress to a debilitating disorder of involuntary movement with variable features, including chorea, tremor, dystonic posturing and orofacial dyskinesia. Additional variable features include ataxia, microcephaly, ophthalmoplegia, ptosis, optic atrophy and axonal peripheral neuropathy.